INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,979 | -72.1% | 7,661 | -67.9% | 0.00% | – |
| Q2 2023 | $10,668 | +3233.8% | 23,867 | -93.9% | 0.00% | – |
| Q1 2023 | $320 | -44.8% | 389,841 | +4.8% | 0.00% | -100.0% |
| Q4 2022 | $580 | -99.9% | 372,002 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $634,000 | +14.6% | 367,251 | +14.9% | 0.00% | 0.0% |
| Q2 2022 | $553,000 | -46.3% | 319,598 | +11.4% | 0.00% | 0.0% |
| Q1 2022 | $1,030,000 | -34.9% | 286,939 | -9.4% | 0.00% | -50.0% |
| Q4 2021 | $1,581,000 | -30.7% | 316,788 | -0.6% | 0.00% | -33.3% |
| Q3 2021 | $2,282,000 | -21.1% | 318,771 | +2.1% | 0.00% | -25.0% |
| Q2 2021 | $2,893,000 | +40.0% | 312,063 | +40.2% | 0.00% | +33.3% |
| Q1 2021 | $2,066,000 | +13.7% | 222,610 | +8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,817,000 | -19.5% | 205,348 | +5.6% | 0.00% | -25.0% |
| Q3 2020 | $2,256,000 | -63.2% | 194,456 | -14.5% | 0.00% | -60.0% |
| Q2 2020 | $6,129,000 | +528.0% | 227,406 | +73.3% | 0.01% | +400.0% |
| Q1 2020 | $976,000 | +129.6% | 131,216 | +2.0% | 0.00% | +100.0% |
| Q4 2019 | $425,000 | +68.0% | 128,638 | +4.3% | 0.00% | – |
| Q3 2019 | $253,000 | -30.7% | 123,348 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $365,000 | -12.9% | 124,248 | +10.6% | 0.00% | 0.0% |
| Q1 2019 | $419,000 | -4.6% | 112,338 | +2.4% | 0.00% | 0.0% |
| Q4 2018 | $439,000 | +7.1% | 109,693 | +48.9% | 0.00% | 0.0% |
| Q3 2018 | $410,000 | +32.7% | 73,668 | -6.7% | 0.00% | 0.0% |
| Q2 2018 | $309,000 | -11.7% | 78,923 | +6.1% | 0.00% | 0.0% |
| Q1 2018 | $350,000 | +18.2% | 74,368 | +3.7% | 0.00% | 0.0% |
| Q4 2017 | $296,000 | -40.6% | 71,708 | -8.8% | 0.00% | 0.0% |
| Q3 2017 | $498,000 | -17.8% | 78,624 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $606,000 | +15.9% | 77,294 | -2.1% | 0.00% | 0.0% |
| Q1 2017 | $523,000 | +2.5% | 78,981 | +7.6% | 0.00% | 0.0% |
| Q4 2016 | $510,000 | -22.1% | 73,418 | +4.5% | 0.00% | -50.0% |
| Q3 2016 | $655,000 | +2.3% | 70,226 | +1.4% | 0.00% | 0.0% |
| Q2 2016 | $640,000 | +2.1% | 69,226 | -3.9% | 0.00% | 0.0% |
| Q1 2016 | $627,000 | +31.7% | 72,013 | +1.8% | 0.00% | 0.0% |
| Q4 2015 | $476,000 | +25.3% | 70,768 | +7.5% | 0.00% | +100.0% |
| Q3 2015 | $380,000 | -28.4% | 65,813 | +1.2% | 0.00% | -50.0% |
| Q2 2015 | $531,000 | +7.5% | 65,025 | +7.5% | 0.00% | +100.0% |
| Q1 2015 | $494,000 | +7.6% | 60,495 | +21.0% | 0.00% | 0.0% |
| Q4 2014 | $459,000 | +34.6% | 49,995 | +44.2% | 0.00% | 0.0% |
| Q3 2014 | $341,000 | +17.6% | 34,670 | +29.0% | 0.00% | 0.0% |
| Q2 2014 | $290,000 | – | 26,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |